Bio-Rad to Participate in the 2021 Virtual Wells Fargo Healthcare Conference
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Business Wire
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that management will participate in a Fireside Chat at the 2021 Virtual Wells Fargo Healthcare Conference on Thursday, September 9, at 11:40 AM (Pacific Time).A link to the live webcast of the presentation will be available in the “Conferences” area of Investor Relations on our website at bio-rad.com.About Bio-RadBio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well a
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition [Yahoo! Finance]Yahoo! Finance
- Norovirus Diagnostics Market To Reach USD 130.4 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- Bio-Rad’s Chief Operating Officer Andrew Last to RetireBusiness Wire
- Recombinant Proteins Market Size Projected to Surge $6.47 Billion Growth by 2033, Exhibit a CAGR of 8% [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. (NYSE: BIO) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
BIO
Earnings
- 2/15/24 - Beat
BIO
Sec Filings
- 4/17/24 - Form 3
- 4/10/24 - Form 8-K
- 3/27/24 - Form ARS
- BIO's page on the SEC website